Cumulative number of COVID-19 vaccine doses administered in India surpasses 19.32 crore: Govt
The cumulative number of COVID-19 vaccine doses administered in the country has surpassed 19.32 crore, the Union Health Ministry said on Friday.
It said 6,63,353 beneficiaries in the age group of 18-44 years received their first dose on Friday, and cumulatively 92,73,550 across 37 states and UTs since the start of phase-3 of the vaccination drive.
The 92,73,550 beneficiaries include 11,83,124 from Rajasthan, 10,60,702 from Bihar, 8,85,881 from Delhi, 6,82,744 from Maharashtra, 9,60,032 from Uttar Pradesh, 6,71,800 from Haryana and 6,02,691 from Gujarat .
The cumulative number of COVID-19 vaccine doses administered in the country stands at 19,32,97,222, according to the provisional report updated till 8 pm.
The total of 19,32,97,222 include 97,37,237 healthcare workers (HCWs) who have taken the first dose and 66,89,893 HCWs who have taken the second dose.
It also includes 1,48,63,770 frontline workers (FLWs) who have received the first dose, 83,05,152 FLWs who have taken the second dose, and 92,73,550 individuals in the 18-44 years of age group who have received the first dose.
Besides, 6,01,86,416 and, 96,79,427 beneficiaries aged 45 to 60 years old have been administered the first and second dose respectively, while, 5,63,74,895 and 1,81,86,882 beneficiaries above 60 years have taken the first and second dose.
As on day-126 of the vaccination drive (21st May), a total of 13,83,358 vaccine doses were given.
The ministry said 12,05,727 beneficiaries were vaccinated for the first dose and 1,77,631 beneficiaries received the second dose of vaccine as per the provisional report till 8 PM. Final reports would be completed for the day by late night.
The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level, the ministry underlined.
ALSO READ: India will be in a position to vaccinate its adult population by end of 2021: Harsh Vardhan
ALSO READ: Delay in second shot of Pfizer vaccine boosts immunity in elderly by over 3 times: Study
